GetTopicDetailResponse(id=6a3c61e2e0, topicName=DOAC, introduction=DOAC, content=null, image=null, comments=1, allHits=2009, url=https://h5.medsci.cn/topic?id=6172, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=39662, tagList=[TagDto(tagId=39662, tagName=DOAC)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2275771, encodeId=16d822e5771b1, content=<a href='/topic/show?id=fa10e93597f' target=_blank style='color:#2F92EE;'>#缺血性卒中#</a> <a href='/topic/show?id=737a54248f5' target=_blank style='color:#2F92EE;'>#房顫#</a> <a href='/topic/show?id=b64035999ca' target=_blank style='color:#2F92EE;'>#卒中#</a> <a href='/topic/show?id=6a3c61e2e0' target=_blank style='color:#2F92EE;'>#DOAC#</a>, objectTitle=平衡卒中預防與出血風險：房顫患者嚴重出血后DOAC重啟時機, objectType=article, longId=889926, objectId=7c54889926be, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/atrial-fibrillation-s1-photo-of-atrial-fibrillation.jpg, objectUrl=/article/show_article.do?id=7c54889926be, replyNumber=0, likeNumber=14, createdTime=2025-08-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=7c54889926be, moduleTitle=平衡卒中預防與出血風險：房顫患者嚴重出血后DOAC重啟時機, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7c54889926be)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1241722, encodeId=cc421241e228b, content=<a href='/topic/show?id=39491046292a' target=_blank style='color:#2F92EE;'>#Asundexian#</a>又是一種新型<a href='/topic/show?id=8516552389b' target=_blank style='color:#2F92EE;'>#抗凝藥#</a>物，不知道與<a href='/topic/show?id=f5f610462e09' target=_blank style='color:#2F92EE;'>#Milvexian#</a>比一比，效果如何？這一類藥物應該是接班沙班類了。與<a href='/topic/show?id=6a3c61e2e0' target=_blank style='color:#2F92EE;'>#DOAC#</a>治療相比,Asundexian通過抑制FXIa可以在不干擾止血的情況下預防<a href='/topic/show?id=23c58911686' target=_blank style='color:#2F92EE;'>#血栓栓塞#</a>,從而大大降低<a href='/topic/show?id=8da8314804a' target=_blank style='color:#2F92EE;'>#出血風險#</a>。, objectTitle=Circulation：新型抗凝劑可預防復發(fā)性缺血性卒中（PACIFIC-Stroke研究）, objectType=article, longId=737263, objectId=9229e37263e8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220828/1661709141854_4754896.png, objectUrl=/article/show_article.do?id=9229e37263e8, replyNumber=0, likeNumber=228, createdTime=2022-08-29, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9229e37263e8, moduleTitle=Circulation：新型抗凝劑可預防復發(fā)性缺血性卒中（PACIFIC-Stroke研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9229e37263e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
